Nagarro (OTC:NGRRF) Stock, Quote.Headers.trade-ideas

Nagarro SE is a digital engineering company. It offers application development and management, digital product engineering, artificial intelligence and machine learning, cloud solutions, digital marketing, IoT solutions, digital commerce solutions, managed services, and others. The company's geographical segment includes North America, Central Europe, Rest of Europe, and Rest of World.

Nagarro SE

<p><strong>David Goubert</strong> has resigned as president and CEO of <strong>Ayr Wellness Inc.</strong> (CSE:<a class="ticker" href="https://www.benzinga.com/stock/AYR#CSE">AYR</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AYRWF#OTC">AYRWF</a>), a Miami-based cannabis multistate operator, after less than a <a href="https://www.benzinga.com/topic/ayr-wellness">year in the role. </a></p>
<p>Goubert, who joined the company as president in October of 2022 and took over as CEO in February 2023, is the latest in a series of executive departures at the company, MJBizDaily <a href="https://mjbizdaily.com/cannabis-operator-ayr-wellness-loses-ceo-david-goubert/">reported.</a></p>
<p><strong>See Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40222855/ayr-wellness-reports-qoq-drop-in-q2-revenue-gross-profit-but-plans-to-make-the-most-of-ohio-cann">AYR Wellness&#8217; Conditional Approval For Medical Marijuana Operations In Virginia, What It Means For Investors</a></strong></p>
<p>The resignation was announced alongside Ayr&#8217;s second-quarter earnings report, which revealed a slight dip in earnings and growing net losses. </p>
<p>Ayr's board of directors has initiated a search for a permanent CEO, while <strong>Steven Cohen</strong>, previously an external legal adviser, will serve as interim CEO.</p>
<h3 class="wp-block-heading">Are Leadership Changes Enough?</h3>
<p>In the second quarter of 2024, the company reported a slight decrease in revenue, down 0.6% from the previous quarter to $117.3 million. </p>
<p>While the MSO managed to reduce its overall expenses, net losses increased to $38 million, a significant jump from the $29 million reported a year earlier.</p>
<p>The company has been attempting to stabilize its financial footing amid these losses. As Goubert explained before his resignation, Ayr was focused on "laying the groundwork for Ayr's next phase of growth."</p>
<h3 class="wp-block-heading">Interim Leadership</h3>
<p>Cohen, who will assume the role of interim CEO, brings a legal and corporate governance background but lacks direct cannabis industry experience. He is a founding member of <strong>Blue Raven,</strong> a New York-based legal advisory firm specializing in strategic corporate advice and general counsel services.</p>
<p>Cohen's appointment follows another notable departure, <strong>Jonathan Sandelman</strong>, who stepped down as director and executive chair in July, marking the second high-profile exit within just a few months.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40222855/ayr-wellness-reports-qoq-drop-in-q2-revenue-gross-profit-but-plans-to-make-the-most-of-ohio-cann">Ayr Wellness Reports QoQ Drop In Q2 Revenue &amp; Gross Profit But Plans To Make The Most Of Ohio Cannabis Sales</a></li>
</ul>
<p><em>Cover image made with AI.</em></p>


Cannabis

Movers & Shakers

Management

Markets

AYRWF

CSE:AYR

Cannabis Multi-State Operator Ayr Wellness Seeks New CEO After David Goubert's Departure: 'Next Phase Of Growth' Coming?

<p><strong>MillerKnoll, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) shares are trading lower after the company reported its first-quarter financial results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/09/n40947407/millerknoll-inc-reports-first-quarter-fiscal-2025-results">details from the report. </a></p>
<p><strong>The Details:</strong> MillerKnoll reported quarterly earnings of 36 cents per share, which missed the analyst consensus estimate of 40 cents. Quarterly revenue of $861.50 million also missed the consensus estimate of $889.3 million and represents a 6.12% decrease from the same period last year.</p>
<ul>
<li>Orders in the first quarter were up 2.4% on a reported basis and up 3.5% organically from the prior year, led by Americas Contract growth of 5.2%.</li>
<li>Ending backlog of $758 million increased 9.2% from last year and 10.9% from the start of fiscal 2025.</li>
<li>Gross margin in the Global Retail segment improved by 160 basis points due to continued benefits from operational improvements.</li>
</ul>
<p>&#8220;While demand trends in our Retail segment continue to reflect the impact of a tepid housing market, the investments we have made in platform operational capabilities are not only driving significant margin improvements, but also position us to support profitable growth plans as the macro-economic backdrop improves. We believe our first quarter financial results demonstrate the advantage of our collective of brands, diverse business channels and global footprint,&#8221; the company wrote in a letter to shareholders. </p>
<p><strong>Read Next: </strong><a href="https://www.benzinga.com/fintech/24/09/40928342/what-happened-with-sofi-stock-today"><strong>What Happened With SoFi Stock Today?</strong></a></p>
<p><strong>Outlook:</strong> MillerKnoll sees second-quarter earnings of between 51 cents and 57 cents per share, versus the estimate of 61 cents, and second-quarter revenue in a range of $950 million to $990 million, versus the $948.12 million estimate. <br />BZ Wire</p>
<p><strong>MLKN Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, MillerKnoll shares are down 2.62% after-hours at $26.75 at the time of publication Thursday. </p>
<p><strong>Read Also:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40923038/whats-going-on-with-carnival-stock"><strong>What&#8217;s Going On With Carnival Stock?</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Earnings

News

Movers

MLKN

MillerKnoll Stock Dips After Q1 Results: Here's Why

<p><strong>Chewy Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) shares are trading lower in Thursday&#8217;s after-hours session after the company announced a public offering by a selling stockholder and a <a href="https://www.benzinga.com/pressreleases/24/09/b40948271/chewy-inc-announces-public-offering-of-class-a-common-stock-by-selling-stockholder-and-concurrent-">concurrent share repurchase</a>.</p>
<p><strong>What Happened:</strong> After the market close, Chewy announced an underwritten offering of&nbsp;$500 million&nbsp;of its common stock by <strong>Buddy Chester Sub LLC</strong>, which is an entity affiliated with funds advised by Chewy&#8217;s largest shareholder <strong>BC Partners Advisors LP</strong>.</p>
<p>The selling stockholder expects to grant the underwriters a 30-day option to purchase up to an additional&nbsp;$75 million&nbsp;of Chewy common stock. The online pet retailer will not sell any shares in the offering or receive any proceeds. </p>
<p>Chewy also agreed to purchase $300 million worth of its common stock from the selling stockholder at a price equal to the price paid by the underwriters in the offering. The repurchased shares will be canceled and retired upon completion of the concurrent repurchase.</p>
<p>Chewy noted that its existing <a href="https://www.benzinga.com/news/earnings/24/05/39064898/pet-supply-focused-chewy-shares-gain-on-better-than-anticipated-q1-earnings-500m-buyback-plan">$500 million share repurchase program</a> will not be affected by this transaction. </p>
<p><strong>Don&#8217;t Miss: <a href="https://www.benzinga.com/news/earnings/24/09/40948046/fedex-q1-earnings-revenue-miss-eps-miss-lowered-guidance-challenging-quarter">FedEx Q1 Earnings: Revenue Miss, EPS Miss, Lowered Guidance — &#8216;Challenging Quarter&#8217;</a></strong></p>
<p><strong>CHWY Price Action:</strong> Chewy shares were down 3.09% in after hours, trading at $30.15 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: <a href="https://pixabay.com/users/huoadg5888-8934889/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=4415649">huoadg5888</a> from Pixabay.</em></p>


Offerings

Buybacks

After-Hours Center

CHWY

Chewy Stock Is Sliding After Hours: What's Going On?

<p>Telsey Advisory Group  analyst Joseph Feldman   maintains Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) with a Outperform and maintains $195 price target.</p>


Price Target

Analyst Ratings

Telsey Advisory Group Maintains Outperform on Target, Maintains $195 Price Target

<p><strong>Lennar Corp </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) reported its third-quarter financial results after Thursday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/09/n40948079/lennar-reports-third-quarter-2024-results">details from the report. </a></p>
<p><strong>The Details:</strong> Lennar reported quarterly earnings of $3.90 per share, which beat the analyst consensus estimate of $3.63 by 7.44%. Quarterly revenue clocked in at $9.416 billion, beating the consensus estimate of $9.164 billion and representing a 7.86% increase over the same period last year.</p>
<ul>
<li>New orders increased 5% to 20,587 homes.</li>
<li>Lennar reported a backlog of 16,944 homes with a dollar value of $7.7 billion.</li>
<li>Deliveries increased 16% to 21,516 homes. </li>
<li>Lennar reported homebuilding operating earnings of $1.5 billion with gross margin on home sales of 22.5%.</li>
<li>Average home price was $422,000 in the third quarter,</li>
</ul>
<p>&#8220;We are pleased to report another solid quarter backed by an economic environment that remains very constructive for homebuilders. Employment was strong, housing supply remained chronically short due to production deficits of over a decade and demand was solid driven by strong household formation,&#8221; said <strong>Stuart Miller</strong>, executive chairman and Co-CEO of Lennar.</p>
<p>&#8220;Although affordability continued to be tested during the quarter, purchasers remained responsive to increased sales incentives, resulting in a 16% increase in our deliveries and a 5% increase in our new orders year over year,&#8221; Miller added.</p>
<p><strong>Read Next: </strong><a href="https://www.benzinga.com/fintech/24/09/40928342/what-happened-with-sofi-stock-today"><strong>What Happened With SoFi Stock Today?</strong></a></p>
<p><strong>Outlook:</strong> Lennar sees fourth-quarter new orders in a range of 19,000 to 19,300 and deliveries between 22,500 and 23,000. The company expects the average sales price to be approximately $425,000.</p>
<p><strong>What Else:</strong> The company will host a conference call at 11 a.m. ET Friday to discuss the results. BofA Securities analyst <strong>Rafe Jadrosich</strong> maintained Lennar with a Neutral rating and raised the price target from $171 to $190 before the print on Thursday.</p>
<p><strong>LEN Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Lennar shares are down 3.36% in extended trading at $185.99 after gaining 2.13% in Thursday&#8217;s regular session.</p>
<p><strong>Read Also:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40923038/whats-going-on-with-carnival-stock"><strong>What&#8217;s Going On With Carnival Stock?</strong></a></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Homebuilder Lennar Reports Better-Than-Expected Q3 Results: Details

<p>West Fraser Timber Co. Ltd. ("West Fraser" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFG#NYSE">WFG</a>) announced today that it will indefinitely curtail its sawmill in Lake Butler, Florida by the end of this month. Today's decision is the result of high fiber costs and soft lumber markets.</p>
<p>The indefinite curtailment of Lake Butler Sawmill will impact approximately 130 employees and reduce West Fraser's U.S. lumber capacity by approximately 110 million board feet. West Fraser expects to mitigate the impact on affected employees by providing work opportunities at other company operations.</p>
<p>High fiber costs at Lake Butler and the current low-price commodity environment have impaired the ability to profitably operate the mill. The indefinite curtailment of Lake Butler sawmill better aligns our U.S. lumber capacity with demand.</p>
<p>West Fraser anticipates taking an impairment charge in the third quarter of 2024 associated with the announcement.</p>


West Fraser Timber Co. Announces It Will Indefinitely Curtail Its Sawmill In Lake Butler, Florida By The End Of This Month, As A Result Of High Fiber Costs And Soft Lumber Markets

<p><strong>Toyota Tsusho Memorandum of Understanding</strong><br /><br />Arcadium Lithium announced the recent signing of a Memorandum of Understanding (MoU) with its long-time partner Toyota Tsusho Corporation (TTC), a key initial step in providing greater flexibility for Arcadium Lithium to optimize its global integrated operating network and to contribute its production expertise to Naraha.&nbsp; This includes using technical grade lithium carbonate produced at Olaroz to feed the Company's existing downstream lithium hydroxide network, thus allowing more battery grade lithium carbonate produced at Fénix to be sold directly to customers.&nbsp; This is expected to have a positive impact on the Company's earnings and to be achievable as early as 2026.</p>


Contracts

ALTM

Arcadium Lithium Announced The Recent Signing Of A MoU With Its Long-Time Partner Toyota Tsusho Corporation To Optimize Its Global Integrated Operating Network And To Contribute Its Production Expertise To Naraha, Expected To Have A Positive Impact On The Co's Earnings And To Be Achievable As Early As 2026

<ul>
<li>Underscores unique position as a vertically integrated, diversified global producer of lithium chemicals with low-cost and high-quality assets</li>
<li>Details ongoing expansion programs expected to more than double total sales volumes by 2028 across multiple products and regions</li>
<li>Outlines path to Adjusted EBITDA1 of $1.3 billion by 2028 supported by strong and flexible balance sheet with peak net leverage of 2.1x1,2</li>
<li>Reaffirms significant expansion potential of one of the largest and most diverse resource bases in the industry</li>
<li>Accelerating plan to deliver $125 million of merger-related cost savings roughly two years ahead of initial target</li>
<li>Executed Memorandum of Understanding (MoU) with Toyota Tsusho in key step to unlocking further synergies</li>
</ul>
<p>Arcadium Lithium plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>, ASX: LTM, ", Arcadium Lithium", &amp;nbsp, or the ", Company", )))), a leading global lithium chemicals producer, today provided a number of strategic updates at its inaugural 2024 Investor Day. &nbsp;During the event, the Company reviewed its operating, commercial and growth strategies while reinforcing its commitment to sustainability leadership.&nbsp; The Company also discussed its plans for disciplined volume expansion and provided a long-term financial view.</p>


Guidance

Events

Arcadium Lithium's 2024 Investor Day Highlights Company's Strategic Vision And Pathway To Significant Growth; Sees Adjusted EBITDA Of $1.3B By 2028; Accelerating Plan To Deliver $125M Of Merger-Related Cost Savings Roughly 2-Years Ahead Of Initial Target

<p>Ratings for QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for QuidelOrtho, revealing an average target of $57.25, a high estimate of $61.00, and a low estimate of $50.00. Surpassing the previous average price target of $51.00, the current average has increased by 12.25%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779707_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>The standing of QuidelOrtho among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Sourbeer</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Alexander Nowak</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$57.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$61.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$61.00</td>
<td>$61.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to QuidelOrtho. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of QuidelOrtho compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of QuidelOrtho's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/QDEL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on QuidelOrtho analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind QuidelOrtho</h2>
<p>QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.</p>
<h3>QuidelOrtho's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining QuidelOrtho's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately <strong>-4.22%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> QuidelOrtho's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-23.19%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> QuidelOrtho's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>-4.56%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> QuidelOrtho's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-2.21%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.87</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


QDEL

Cracking The Code: Understanding Analyst Reviews For QuidelOrtho

<p>4 analysts have expressed a variety of opinions on Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.5, a high estimate of $9.00, and a low estimate of $8.00. Witnessing a positive shift, the current average has risen by 9.68% from the previous average price target of $7.75.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779681_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Hain Celestial Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Andrew Lazar</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Brian Holland</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Matthew Smith</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$9.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Hain Celestial Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hain Celestial Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Hain Celestial Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Hain Celestial Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HAIN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Hain Celestial Group analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Hain Celestial Group</h2>
<p>The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby &amp; kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.</p>
<h3>Unraveling the Financial Story of Hain Celestial Group</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Hain Celestial Group's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately <strong>-6.48%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.</p>
<p><strong>Net Margin:</strong> Hain Celestial Group's net margin excels beyond industry benchmarks, reaching <strong>-0.7%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Hain Celestial Group's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-0.31%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Hain Celestial Group's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-0.14%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.89</strong>.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


HAIN

Demystifying Hain Celestial Group: Insights From 4 Analyst Reviews

<p>In the latest quarter, 4 analysts provided ratings for Harley-Davidson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOG#NYSE">HOG</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $40.75, a high estimate of $44.00, and a low estimate of $39.00. Witnessing a positive shift, the current average has risen by 4.49% from the previous average price target of $39.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779669_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A clear picture of Harley-Davidson's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Robin Farley</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$44.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Craig Kennison</td>
<td>Baird</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Harley-Davidson. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Harley-Davidson compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Harley-Davidson's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Harley-Davidson's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HOG/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Harley-Davidson analyst ratings.</strong></a></p>
<h2>All You Need to Know About Harley-Davidson</h2>
<p>Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 38% of the heavyweight domestic market in 2023.</p>
<h3>A Deep Dive into Harley-Davidson's Financials</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Harley-Davidson's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>11.99%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Harley-Davidson's net margin is impressive, surpassing industry averages. With a net margin of <strong>13.48%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>6.44%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Harley-Davidson's ROA excels beyond industry benchmarks, reaching <strong>1.74%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.19</strong>, Harley-Davidson faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Verdict: Harley-Davidson In The Eyes Of 4 Experts

<p>During the last three months, 7 analysts shared their evaluations of Driven Brands Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRVN#NASDAQ">DRVN</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Driven Brands Hldgs and provided 12-month price targets. The average target is $17.29, accompanied by a high estimate of $20.00 and a low estimate of $14.00. This current average reflects an increase of 5.88% from the previous average price target of $16.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779659_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive Driven Brands Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian McNamara</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>John Lawrence</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Tristan Thomas-Martin</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$14.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Driven Brands Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Driven Brands Hldgs compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Driven Brands Hldgs's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Driven Brands Hldgs's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DRVN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Driven Brands Hldgs analyst ratings.</strong></a></p>
<h2>Get to Know Driven Brands Hldgs Better</h2>
<p>Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.</p>
<h3>Driven Brands Hldgs: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Driven Brands Hldgs's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of <strong>0.78%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>4.93%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>3.26%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Driven Brands Hldgs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.51%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>4.46</strong>, caution is advised due to increased financial risk.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DRVN

Forecasting The Future: 7 Analyst Projections For Driven Brands Hldgs

<p>Ratings for Elanco Animal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $18.0, along with a high estimate of $21.00 and a low estimate of $15.00. Highlighting a 8.86% decrease, the current average has fallen from the previous average price target of $19.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779650_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of Elanco Animal Health among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Erin Wright</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>David Westenberg</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Balaji Prasad</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$21.00</td>
<td>$23.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Elanco Animal Health. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Elanco Animal Health compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Elanco Animal Health's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Elanco Animal Health's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ELAN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Elanco Animal Health analyst ratings.</strong></a></p>
<h2>All You Need to Know About Elanco Animal Health</h2>
<p>Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.</p>
<h3>Elanco Animal Health's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Elanco Animal Health's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately <strong>12.02%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> Elanco Animal Health's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>-4.22%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Elanco Animal Health's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-0.83%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Elanco Animal Health's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-0.36%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> Elanco Animal Health's debt-to-equity ratio is below the industry average at <strong>0.96</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ELAN

Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews

<p>Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on MP Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>) in the last three months.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;"><strong>Bullish</strong></th>
<th style="text-align: right;"><strong>Somewhat Bullish</strong></th>
<th style="text-align: right;"><strong>Indifferent</strong></th>
<th style="text-align: right;"><strong>Somewhat Bearish</strong></th>
<th style="text-align: right;"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for MP Materials, presenting an average target of $19.12, a high estimate of $30.00, and a low estimate of $12.50. This current average represents a 5.77% decrease from the previous average price target of $20.29. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726779624_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>A comprehensive examination of how financial experts perceive MP Materials is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carlos De Alba</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>$13.50</td>
</tr>
<tr>
<td>George Gianarikas</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Corinne Blanchard</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$12.50</td>
<td>$13.50</td>
</tr>
<tr>
<td>Subash Chandra</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Greg Jones</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$16.50</td>
<td>-</td>
</tr>
<tr>
<td>Lawson Winder</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MP Materials. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of MP Materials compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for MP Materials's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into MP Materials's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MP/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on MP Materials analyst ratings.</strong></a></p>
<h2>About MP Materials</h2>
<p>MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America.</p>
<h3>Unraveling the Financial Story of MP Materials</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, MP Materials faced challenges, resulting in a decline of approximately <strong>-51.18%</strong> in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> MP Materials's net margin is impressive, surpassing industry averages. With a net margin of <strong>-108.95%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> MP Materials's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-3.03%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> MP Materials's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>-1.44%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> MP Materials's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.85</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Landscape: 8 Takes On MP Materials

<p>Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) ("Diamondback") announced today the launch of an underwritten public offering of 11,270,000 shares of its common stock by certain Legacy Endeavor Stockholders (the "Selling Stockholders"), subject to market and other conditions (the "Secondary Offering"). Diamondback will not receive any proceeds from the sale of the shares by the Selling Stockholders. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,390,500 shares of common stock.<br /><br />&nbsp;</p>
<p>In addition, Diamondback has authorized the purchase from the underwriters of 2,000,000 shares of common stock offered in the Secondary Offering (the "Share Repurchase"). The Share Repurchase is part of the Diamondback's existing share repurchase program. Diamondback intends to fund the Share Repurchase from existing cash on hand. The underwriters will not receive any compensation for the shares being repurchased by Diamondback in the Share Repurchase.</p>
<p>Evercore ISI, Citigroup and J.P. Morgan are acting as joint book-running managers for the Secondary Offering.</p>


FANG

Diamondback Energy Announces Launch Of Secondary Common Stock Offering Of 11.27M Shares Of Common Stock; Diamondback Has Authorized The Purchase From The Underwriters Of 2M Shares Of Common Stock Offered In The Secondary Offering As Part Of Its Existing Repurchase Program

<p>After a bullish session on Thursday, with both the S&amp;P 500 and the Dow Jones hitting record highs, spurred by increased risk appetite following a bold 0.5% rate cut by the Federal Reserve, traders are gearing up for a volatile <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40944143/wall-street-breaks-records-chipmakers-rally-tesla-hits-2-month-high-as-fed-cut-drives-risk">end to the week.</a></p>
<p>Friday marks a notorious &#8220;Triple Witching&#8221; day, when stock index futures, stock index options and individual stock options expire simultaneously — a convergence that historically stirs market turbulence.</p>
<p>Goldman Sachs estimates than more than $4.5 trillion in notional options exposure will expire on Friday, including $605 billion in single-stock options.  </p>
<p>According to Bloomberg, using estimates from derivatives analytical firm Asym 500, the overall notional options expiring Friday reach $5.1 trillion when including options tied to ETFs.</p>
<p>&#8220;This Friday will be the largest September-options expiration on record, driven by elevated index and ETF options volumes,&#8221; wrote Goldman Sachs analyst <strong>John Marshall</strong>. </p>
<p>While the September expiration will set a new record, it&#8217;s expected to be smaller than the previous quarterly expirations of 2024.</p>
<h3 class="wp-block-heading">A Record-Breaking Expiration Day</h3>
<p>Goldman Sachs highlighted that average daily index and ETF options volumes have reached a new high this quarter. In contrast, single-stock options trading has seen a decline. </p>
<p>The sheer magnitude of options expiring Friday could trigger a wave of volatility as traders scramble to adjust their position, and the Federal Reserve&#8217;s recent rate cut might not be enough to temper the storm.</p>
<p>Could this triple witching day spoil the market rally ignited by the Fed?</p>
<h3 class="wp-block-heading">What Is &#8216;Triple Witching&#8217;? How Did Markets Previously Perform? </h3>
<p>Triple witching refers to the simultaneous expiration of three types of derivative contracts — stock index futures, stock index options and single-stock options — on the same day, occurring quarterly on the third Friday of March, June, September and December.</p>
<p>This convergence can lead to heightened market volatility as traders close, roll over or offset their expiring contracts, often resulting in unusual price movements and increased trading volumes.</p>
<p>Looking back at the last three triple witching events, the S&amp;P 500, tracked by the <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), has struggled during these high-stakes trading days.</p>
<ul>
<li><strong>June 21, 2024:</strong> The S&amp;P 500 dropped 0.5%.</li>
<li><strong>March 15, 2024:</strong> The index fell by 1%.</li>
<li><strong>Dec. 15, 2023:</strong> The S&amp;P 500 declined 0.6%.</li>
</ul>
<p>Tech stocks, represented by the<strong> Invesco QQQ Trust</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), underperformed in the last two triple witching occasions, falling 0.8% in June and 1.2% in March, while surging 0.5% in December 2023. </p>
<h3 class="wp-block-heading">Goldman Sachs Recommends VIX Calls Ahead of Volatility Spike</h3>
<p>September is historically the worst month for stock market performance.</p>
<p>According to <strong>Ryan Detrick</strong>, chief market strategist at Carson Group, the last two weeks of September are the worst period for stocks during the year, as the expert showed in a post on social media platform X.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">You are here.<br /><br />The worst two weeks of the year for stocks. <a href="https://t.co/kXDg0lXKOX">pic.twitter.com/kXDg0lXKOX</a></p>
<p>&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1835859506221461664?ref_src=twsrc%5Etfw">September 17, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>The CBOE Volatility Index (VIX), often referred to as the market&#8217;s fear gauge, has dropped significantly since its spike in August.</p>
<p>The index is sitting at 17, well below its multiyear average, and Goldman Sachs sees the VIX on the rise as we enter the seasonally volatile period.</p>
<p>Goldman Sachs&#8217; economic model estimates that, given macroeconomic conditions, the VIX should be at 24.5, suggesting the current low volatility may not last much longer.</p>
<p>The investment bank issued a recommendation for investors to hedge their portfolios using VIX calls. Specifically, Goldman Sachs analysts advise buying CBOE Volatility Index (VIX) November calls at a strike price of 18.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/technicals/24/09/40942814/boeing-braces-for-turbulence-as-strikes-furloughs-send-stock-sliding-bearish-signals-pre">Boeing Braces For Turbulence As Strikes, Furloughs Send Stock Sliding, Bearish Signals Prevail</a></strong></li>
</ul>
<p><em>Photo via Shutterstock. </em></p>


Analyst Color

Equities

Broad U.S. Equity ETFs

Previews

Options

Tech

ETFs

Traders Brace For Friday Volatility As Over $5 Trillion In Options Expire: Could 'Triple Witching' Spoil Fed's Rally?

<p><strong>Nike Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) shares are jumping in Thursday&#8217;s after-hours session after the company <a href="https://www.benzinga.com/pressreleases/24/09/b40947704/nike-inc-board-of-directors-announces-long-time-nike-veteran-elliott-hill-to-return-as-president-a">announced a CEO transition</a>.</p>
<p><strong>What Happened:</strong> After the market close on Thursday, Nike announced that longtime Nike veteran <strong>Elliott Hill</strong> will become president and CEO of Nike, effective Oct. 14. Hill will also become a director on the board and a member of the executive committee.</p>
<p>The board and<strong> John Donahoe</strong> made the decision that Donahoe will retire from his role as president and CEO of Nike, effective Oct. 13. The exiting CEO will remain an advisor to the company through Jan. 31, 2025, to ensure a smooth transition.</p>
<p>&#8220;Given our needs for the future, the past performance of the business, and after conducting a thoughtful succession process, the Board concluded it was clear Elliott&#8217;s global expertise, leadership style, and deep understanding of our industry and partners, paired with his passion for sport, our brands, products, consumers, athletes, and employees, make him the right person to lead Nike&#8217;s next stage of growth,&#8221; said <strong>Mark Parker</strong>, executive chairman of Nike.</p>
<p>&#8220;Personally, I have worked with Elliott for more than 30 years and I look forward to supporting him and his senior management team as they seize the opportunities ahead.&#8221;</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/news/24/09/40941277/whats-going-on-with-nike-stock">What&#8217;s Going On With Nike Stock?</a></strong></p>
<p>Throughout his career at Nike, Hill held senior leadership positions across Europe and North America before retiring in 2020. Before his retirement, he was president of the company&#8217;s Consumer and Marketplace divisions, leading operations for Nike and Jordan brands.</p>
<p>&#8220;For 32 years, I&#8217;ve had the privilege of working with the best in the industry, helping to shape our company into the magical place it is today,&#8221; Hill said. </p>
<p>&#8220;I&#8217;m eager to reconnect with the many employees and trusted partners I&#8217;ve worked with over the years, and just as excited to build new, impactful relationships that will move us ahead.&#8221;</p>
<p><strong>NKE Price Action:</strong> Nike shares closed Thursday up 0.099%. At publication time, the stock was up 10.01% at $89.09 in extended trading, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: Shutterstock.</em></p>


Sports

Nike Stock Jumps 9% After The Bell, CEO Set To Retire

WIIM

BATL

Battalion Oil Corp shares are trading higher after the company announced it has amended its merger agreement with Fury Resources for the acquisition of all outstanding shares of Battalion at $7.00 per share in cash.

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Lowe's Companies</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with LOW, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 21 uncommon options trades for Lowe's Companies.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 42% bullish and 42%, bearish.</p>
<p>Out of all of the special options we uncovered, 6 are puts, for a total amount of $233,364, and 15 are calls, for a total amount of $1,029,627.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $280.0 for Lowe's Companies during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Lowe's Companies options trades today is 1165.5 with a total volume of 3,971.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Lowe's Companies's big money trades within a strike price range of $200.0 to $280.0 over the last 30 days.</p>
<h3>Lowe's Companies Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726778848_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.3</td>
<td>$7.25</td>
<td>$7.3</td>
<td>$280.00</td>
<td>$221.9K</td>
<td>1.5K</td>
<td style="text-align: right;">344</td>
</tr>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$11.2</td>
<td>$11.15</td>
<td>$11.15</td>
<td>$250.00</td>
<td>$200.5K</td>
<td>2.0K</td>
<td style="text-align: right;">261</td>
</tr>
<tr>
<td>LOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.4</td>
<td>$260.00</td>
<td>$76.6K</td>
<td>189</td>
<td style="text-align: right;">204</td>
</tr>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$11.35</td>
<td>$11.3</td>
<td>$11.3</td>
<td>$250.00</td>
<td>$73.7K</td>
<td>2.0K</td>
<td style="text-align: right;">414</td>
</tr>
<tr>
<td>LOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$250.00</td>
<td>$71.5K</td>
<td>3.0K</td>
<td style="text-align: right;">56</td>
</tr>
</tbody>
</table>
</p>
<h3>About Lowe's Companies</h3>
<p>Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.</p>
<p>After a thorough review of the options trading surrounding Lowe's Companies, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Lowe's Companies Standing Right Now?</h3>
<ul>
<li>With a volume of 2,187,069, the price of LOW is up 1.7% at $261.0. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 61 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lowe's Companies</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $245.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Telsey Advisory Group persists with their Market Perform rating on Lowe's Companies, maintaining a target price of $230.<br />
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Hold rating on Lowe's Companies with a target price of $265.<br />
&#x2A; Consistent in their evaluation, an analyst from Gordon Haskett keeps a Hold rating on Lowe's Companies with a target price of $240.<br />
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Lowe's Companies, maintaining a target price of $255.<br />
&#x2A; An analyst from RBC Capital has decided to maintain their Sector Perform rating on Lowe's Companies, which currently sits at a price target of $238. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Lowe's Companies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Check Out What Whales Are Doing With LOW

<p>Financial giants have made a conspicuous bearish move on Procter &amp; Gamble. Our analysis of options history for Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) revealed 9 unusual trades.</p>
<p>Delving into the details, we found 33% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $215,436, and 7 were calls, valued at $548,283.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $155.0 and $180.0 for Procter &amp; Gamble, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $155.0 to $180.0 in the last 30 days. </p>
<h3>Procter &amp; Gamble 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1726778843_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.95</td>
<td>$4.9</td>
<td>$4.95</td>
<td>$180.00</td>
<td>$315.9K</td>
<td>1.4K</td>
<td style="text-align: right;">38</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$3.9</td>
<td>$3.7</td>
<td>$3.75</td>
<td>$175.00</td>
<td>$187.5K</td>
<td>2.7K</td>
<td style="text-align: right;">600</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$1.95</td>
<td>$1.94</td>
<td>$1.95</td>
<td>$175.00</td>
<td>$55.6K</td>
<td>14.8K</td>
<td style="text-align: right;">611</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$0.79</td>
<td>$0.53</td>
<td>$0.79</td>
<td>$172.50</td>
<td>$53.6K</td>
<td>1.4K</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$8.4</td>
<td>$8.1</td>
<td>$8.2</td>
<td>$175.00</td>
<td>$36.8K</td>
<td>129</td>
<td style="text-align: right;">45</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<p>After a thorough review of the options trading surrounding Procter &amp; Gamble, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Procter &amp; Gamble Standing Right Now?</h3>
<ul>
<li>With a trading volume of 8,632,563, the price of PG is down by -1.37%, reaching $171.54.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 27 days from now.</li>
</ul>
<h3>Expert Opinions on Procter &amp; Gamble</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $188.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Procter &amp; Gamble, targeting a price of $186.<br />
&#x2A; In a positive move, an analyst from DZ Bank has upgraded their rating to Buy and adjusted the price target to $190. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Procter &amp; Gamble options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


This Is What Whales Are Betting On Procter & Gamble

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Tech has been by far the fastest-growing industry in the last two decades, with <a href="https://investorplace.com/industries/technology/">tech stocks</a> driving&nbsp;a lot&nbsp;of the hype and enthusiasm in the stock market. For years&nbsp;now, tech has been the primary engine behind the broader market&rsquo;s gains. Not only are the major tech giants continuing their relentless expansion, but we are also seeing spillover effects as technological innovations supercharge other industries.&nbsp;Fields like healthcare, manufacturing, and transportation are being reshaped by advancements in artificial intelligence, robotics, the Internet of Things, and more.</p>



<p>With so much transformative change underway, I believe now is an opportune time to invest in some&nbsp;of the&nbsp;lesser-known tech stocks before they capture Wall Street&rsquo;s attention. The tech industry is creating new companies and opportunities faster than ever before.&nbsp;While the spotlight shines brightly on Big Tech,&nbsp;there are&nbsp;plenty of up-and-coming tech firms still flying under the radar.&nbsp;These stocks remain unknown to most investors, overlooked and undervalued. However, they have massive growth potential&nbsp;ahead&nbsp;if management can execute effectively and capitalize on the&nbsp;huge&nbsp;market opportunities. Here are seven such tech stocks:</p>



<h2>Tech Stocks: X-FAB Silicon Foundries (XFABF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/semiconductor1600b-300x169.jpg" alt="In Ultra Modern Electronic Manufacturing Factory Design Engineer in Sterile Coverall Holds Microchip with Gloves and Examines it. Semiconductor stocks to sell. Undervalued Semiconductor Stocks"><div>Source: Shutterstock</div></div><p><strong>X-FAB Silicon Foundries</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/xfabf-stock-quote/"><strong>XFABF</strong></a>) is a leading foundry group for analog/mixed-signal semiconductor applications.&nbsp;It specializes in producing and selling analog/mixed-signal IC, micro-electro-mechanical systems, and silicon carbide products for automotive, medical, industrial, communication, and consumer sectors&nbsp;worldwide.&nbsp;The company also offers design support for electronic design automation platforms. Despite the booming semiconductor industry, XFABF stock hasn&rsquo;t fared well recently. The stock is down 42% from its peak in August 2023,&nbsp;mostly&nbsp;due to the slowdown in the automotive industry, which forms core demand. As people make fewer big purchases amid high interest rates, automotive chip demand has declined significantly.</p>



<p>However,&nbsp;I believe&nbsp;the current entry point could lead to explosive returns, as we are likely at a cyclical low. A turnaround after rates eventually come down could send the stock much higher. The valuation here looks very cheap compared to growth, trading at just&nbsp;6&nbsp;times earnings. The <a href="https://www.gurufocus.com/stock/XFABF/summary">3-year revenue growth rate is 28.4%</a>, better than 84% of semiconductor peers. Future 3 to 5-year annual revenue growth is 19%, topping 92% of semiconductor companies. <em>Gurufocus</em> puts XFABF&rsquo;s fair value at $24.4 by&nbsp;the end of&nbsp;2027. I see the stars aligning for a&nbsp;major&nbsp;rebound.</p>



<h2>DroneShield Limited (DRSHF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-9-300x169.jpg" alt="stock button on a computer keyboard (representing best investments to start 2021. stocks to buy"><div>Source: Shutterstock</div></div><p><strong>DroneShield Limited</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/drshf-stock-quote/"><strong>DRSHF</strong></a>) has been having explosive growth in recent months, up 343% in the past six months. It&rsquo;s easy to see why when examining what this innovative company does.&nbsp;DroneShield&nbsp;engages in developing, commercializing, and selling&nbsp;hardware and software tech for drone detection and security.&nbsp;With tensions heating up and drones likely being the future of warfare, DroneShield has&nbsp;huge&nbsp;potential as a pure-play in the sector. Valuations could quickly swell as it continues&nbsp;landing&nbsp;more government contracts. Quintupling from current levels seems plausible if growth persists.</p>



<p>Its <a href="http://www.gurufocus.com/stock/DRSHF/summary">90%+ 3-year revenue growth rate</a> bests 99% of peers, and I expect rapid expansion to continue as DroneShield secures more defense contracts.&nbsp;This&nbsp;is a cutting-edge company operating in a crucial growth industry. While it has already made big moves, more upside lies ahead as drone tech becomes increasingly critical for governments worldwide. DroneShield finds itself in the right place at the right time to capitalize.</p>



<h2>Tech Stocks: Nagarro (NGRRF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/ai-stocks1600-7-300x169.png" alt="AI Artificial Intelligence. Businessman using AI technology for data analysis, coding computer language with digital brain, machine learning on virtual screen, business intelligence. AI stocks"><div>Source: Tapati Rinchumrus / Shutterstock.com</div></div><p><strong>Nagarro</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/ngrrf-stock-quote/"><strong>NGRRF</strong></a>) is a digital engineering company offering services including AI and data analytics &ndash; some of the hottest sectors currently. Unfortunately, I can&rsquo;t say the same for the stock. NGRRF is down almost 70% from its peak and sliding lower. However, I foresee the company stabilizing and recovering in the coming months as double-digit revenue growth resumes. <a href="https://seekingalpha.com/symbol/NGRRF/earnings/estimates">Revenue&nbsp;is projected&nbsp;to grow from $1.1 billion in 2024 to $3 billion in 2033</a> &ndash; modest for a tech stock but with a compelling valuation.</p>



<p>Trading at 18 times earnings, I&rsquo;m banking on margin expansion from the current <a href="https://www.gurufocus.com/stock/NGRRF/summary">5.7% net margin</a> as economic conditions improve and EPS expands. Once Nagarro starts executing again, we could see huge upside. It also has an attractive 2.83% forward dividend yield while you wait. This overlooked stock could bounce back in a big way once tech recovers. With its digital engineering expertise spanning AI and analytics, Nagarro is well-positioned for the future. It currently trades at $73, but <em>Gurufocus</em> sees a fair price value of $347 by the end of 2027.</p>



<h2>Aehr Test Systems (AEHR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/stocks-to-buy-1600-300x169.jpg" alt="Stocks to buy: smartphone with the words &quot;buy&quot; and &quot;sell&quot; displayed on the screen. The user's finger is about to press buy. Stock charts are in the background of the image. Momentum Stocks. S&amp;P 600 Stocks to Buy. breakthrough stocks. Mario Gabbeli stocks"><div>Source: Chompoo Suriyo / Shutterstock.com</div></div><p>I have said before that the automotive industry was facing a lot of problems due to rate hikes and the ensuing slump in demand. This has caused companies that have the automotive sector as a big customer source to slump as well. <strong>Aehr Test Systems</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/aehr-stock-quote/"><strong>AEHR</strong></a>) is one such company. Aehr Test Systems is a global provider of test systems for burning-in and testing logic, optical, and memory integrated circuits. They specialize in wafer level, and package part form testing. Their systems are used in various sectors including silicon carbide (SiC), gallium nitride (GaN), and optical photonics. Automotive chips are a core part of the company&rsquo;s business and the stock has 79% from its peak in Sep. 2023.</p>



<p>That said, I think AEHR can bounce back in the coming quarters as rates increase and automotive chips come in demand again. Regardless, I would warn that this company does not have the most reliable management. Guidance was cut twice in the past two months and we are looking at growth remaining flat next year as well. Thus, near-term bleeding could happen. But if you look at the long term, AEHR is still a bargain. Once rates are cut and EV sales volumes start rising, multibagger returns aren&rsquo;t out of the question in 24-36 months. It is a profitable company with a <a href="https://www.gurufocus.com/stock/AEHR/summary">21.4% net margin</a>, so it certainly isn&rsquo;t going to zero anytime soon.</p>



<h2>Tech Stocks: Naspers (NPSNY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/npsny-stock-1-300x169.jpg" alt="a hand holding a phone displaying the Naspers website"><div>Source: Piotr Swat / Shutterstock.com</div></div><p><strong>Naspers</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/npsny-stock-quote/"><strong>NPSNY</strong></a>) is a multinational company operating in the consumer internet industry. It holds investments in classifieds, food delivery, payments and fintech, education, health, and e-commerce. This stock&rsquo;s performance hasn&rsquo;t been as bad as AEHR, but it has been lackluster. The stock has had many ups and downs over the past few years, but it has been essentially flat since 2017.</p>



<p>However, the core fundamentals have been strengthening, and I believe the market is heavily underpricing the stock. Many other analysts agree with me here. This company is <a href="https://seekingalpha.com/symbol/NPSNY/earnings/estimates">expected to see double-digit sales growth</a> moving forward along with EPS bouncing back by 115% this year and growing 14% next year. Moreover, this company has $20 billion in cash against $16.2 billion in debt. The debt load does cause a lot of pain due to interest payments, but as rates come down, this too should turn into a tailwind.</p>



<p>The company has substantial holding in <strong>Tencent Holdings</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/tcehy-stock-quote/"><strong>TCEHY</strong></a>) and other publicly listed, mark-to-market non-operating assets which are also expected to bounce back significantly over the coming years. It also <a href="https://www.gurufocus.com/stock/NPSNY/summary">yields a modest 0.27% dividend</a>. Gurufocus the fair price at $127 by the end of 2026. Its current price is just $34 and I don&rsquo;t see much downside risk from here.</p>



<h2>Ubiquiti (UI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-300x169.jpg" alt='high-growth stocks an image of "Buy" on colorful buttons of the keyboard'><div>Source: Christian Chan / Shutterstock.com</div></div><p><strong>Ubiquiti</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/ui-stock-quote/"><strong>UI</strong></a>) is a technology company that manufactures and sells wireless data communication and wired products for enterprises and homes. Their industry-leading products are unified in an incredible software interface with scalable, license-free cloud management. This is another stock that is down significantly but could soon bottom out and deliver significant gains. There are&nbsp;definitely&nbsp;near-term risks here, but if you are chasing big gains in the long run, the near-term downside risk shouldn&rsquo;t matter much.</p>



<p>The company has very good margins and profitability metrics, and the dividend yield is at 2.3%. <a href="https://seekingalpha.com/symbol/UI/earnings/estimates">Growth is expected to restart next year</a>, with EPS bouncing back by 26% and revenue growing by 18.5%. This means you&rsquo;re paying just 13 times the 2025 expected EPS. I believe it can perform much better than analysts expect once the broader telecommunications industry bounces back. Most telecom companies are laden with debt and are busy with interest payments. But once cash frees up post-rate cuts, we should see growth reignite significantly. <em>Gurufocus</em> puts the fair price value for the stock at $309.</p>



<h2>Tech Stocks: Xinyi Solar Holdings (XISHY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/06/best_stocks_to_buy_now_google-300x169.jpg" alt="best investments: a hand using the touchpad on a laptop. a concept image of figures and charts is emerging from the laptop screen. overlooked stocks to buy"><div>Source: Shutterstock</div></div><p><strong>Xinyi Solar</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/xishy-stock-quote/"><strong>XISHY</strong></a>) is a photovoltaic glass manufacturer. It specializes in photovoltaic glass production and solar farm development. The company provides photovoltaic glass products to major PV module manufacturers globally. As of December 2023, it had six major photovoltaic glass production bases.</p>



<p>The entire solar sector has been seeing a downturn, but many solar companies are starting to bottom out, and there is a huge growth runway here in the long run. Xinyi has also seen its stock price decline, but I believe it can bottom out and recover soon as its top and bottom lines have continued to grow very fast. Its <a href="https://www.google.com/finance/quote/XISHY:OTCMKTS">top line grew almost 30%</a> for all of 2023. Net margin did decline by 15.4%, but with revenue continuing to grow fast, I expect that to bounce back soon.</p>



<p>Analysts <a href="https://seekingalpha.com/symbol/XISHY/earnings/estimates">expect 26.5% revenue growth this year</a> and 22% growth next year. Paying 11 times earnings seems&nbsp;really&nbsp;cheap as it also has a 4.15% forward dividend yield. Its <a href="https://www.gurufocus.com/stock/XISHY/summary">future 3 to 5-year revenue growth is better than 93% of peers</a>. All it needs right now is a margin recovery.</p>



<p><em>On the date of publication, Omor Ibne Ehsan did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>
<div><p>Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on <a href="https://www.linkedin.com/in/omor-ibne-ehsan-56068022b/">LinkedIn</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/04/7-unknown-tech-stocks-that-could-quintuple-your-money-in-2024/">7 Unknown Tech Stocks That Could Quintuple Your Money in 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Unknown Tech Stocks That Could Quintuple Your Money in 2024

Analyst Martin Comtesse from Jefferies maintained a Buy rating on Nagarro SE (NGRRF – Research Report) and keeping the price target at €112.00. Mar...

Nagarro SE Earns 'Buy' Rating with Strong Q1 Performance and Solid FY24 Outlook

Nagarro SE reports Q1 results

Nagarro SE (NGRRF) Q1 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Uber Technologies (UBER – Research Report), Nagarro ...

Analysts Offer Insights on Technology Companies: Uber Technologies (UBER), Nagarro SE (OtherNGRRF) and Life360 Shs Chess Depository Interests Repr 3 Sh (OtherLIFX)

Analyst Fabian Piasta of Jefferies maintained a Buy rating on Nagarro SE (NGRRF – Research Report), with a price target of €112.00. Fabian Piasta's...

Nagarro SE: A Resilient Performance Defying Market Sentiment

Nagarro SE reports 1H results

Nagarro SE (NGRRF) Q2 2024 Earnings Call Transcript

Warburg Research analyst Andreas Wolf maintained a Buy rating on Nagarro SE (NGRRF – Research Report) today and set a price target of €170.00. The ...

Warburg Research Sticks to Their Buy Rating for Nagarro SE (NGRRF)

Jefferies analyst Martin Comtesse maintained a Buy rating on Nagarro SE (NGRRF – Research Report) today and set a price target of €105.00. The comp...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Nagarro

Nagarro (NGRRF) Forecast

Nagarro (OTC:NGRRF) Stock, Quote.Headers.trade-ideas